Back to search

University of Illinois at Urbana-Champaign

Mechanistic studies of lanthipeptide biosynthetic enzymes and discovery of novel lanthipeptides

Abstract

dc:description

Natural products and their derivatives have been a significant source of therapeutic compounds, making up two-thirds of all drugs approved between 1981 and 2019. Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a diverse class of natural products capable of exhibiting diverse biological activities. Lanthipeptides make up a large portion of known RiPPs, characterized by thioether crosslinks. Lanthipeptides contain diverse ring patterns that can be installed by five different classes of enzymes, some of which exhibit great substrate tolerance that can be exploited for bioengineering purposes. Novel lanthipeptides have been identified using both library generation and bioinformatic guided discovery. ProcM is a class II lanthipeptide synthetase that has been utilized for the generation of several lanthipeptide libraries because of its remarkable substrate tolerance. These lanthipeptide libraries have been met with varying degrees of success due in large part to the inability to accurately predict the final ring pattern produced by ProcM on the basis of substrate sequence. Chapter 2 describes several methods as possible means to predict the installed ring patterns as well as ProcM cyclization mechanism studies. The ability to accurately make these predictions would allow for better generation of libraries and the design of lanthipeptides with a defined three-dimensional structure. Mechanistic studies of the class I lanthipeptide biosynthetic enzyme, PciB, were also performed to determine the method of substrate recognition in Chapter 3. This biosynthetic gene cluster was identified via bioinformatic guided discovery and was selected in part because the genetically encoded precursor peptide lacked the canonical FNLD recognition motif. Another example of utilizing bioinformatic methods for identification of novel lanthipeptides is the discovery of roseocin. Roseocin is a two-component lanthipeptide with reported bioactivity against several clinically relevant pathogens. Bioinformatic analysis of the roseocin peptides suggests both contain novel ring patterns compared to other two-component lanthipeptides. Chapter 4 will focus on the structural characterization of roseocin via advanced Marfey’s and NMR analysis.

Degree

thesis:*
Name thesis:degree_name
Ph.D.
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemistry
Grantor
University of Illinois at Urbana-Champaign
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Desormeaux, Emily K.
Contributors dc:contributor
  • van der Donk, Wilfred A
  • Mitchell, Douglas A
  • Mehta, Angad P
  • Manesis, Anastasia C

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • Copyright 2024 Emily Desormeaux
Language dc:language
en, eng

Identifiers

dc:identifier.*
Handle dc:identifier
https://hdl.handle.net/2142/124653

Chain of custody

source
Harvested from
University of Illinois - Urbana-Champaign
Base URL
www.ideals.illinois.edu/oai-pmh
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Desormeaux, Emily K.. Mechanistic studies of lanthipeptide biosynthetic enzymes and discovery of novel lanthipeptides. Dissertation thesis, University of Illinois at Urbana-Champaign, 2024. https://hdl.handle.net/2142/124653